A 90 Day, Phase 3,Open Labeled Exploratory Study of RELiZORB — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A 90 Day, Phase 3,Open Labeled Exploratory Study of RELiZORB — Stella

Home/Short Bowel Syndrome/

View on ClinicalTrials.gov

Recruiting

Back to Short Bowel Syndrome trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

Boston Children's Hospital, Boston, Massachusetts

Key details

Sponsor

Boston Children's Hospital

Collaborators

Alcresta Therapeutics, Inc.

Enrollment target

~32 participants

Started

November 2018

Primary completion

June 2027

Age range

2 Years – 18 Years

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.